For community-dwelling older men, low serum sodium is associated with cognitive impairment and cognitive decline.
Investigators sought to examine factors that influence a cognitively normal individual's risk for developing symptoms of mild cognitive impairment due to Alzheimer disease.
HIV-positive patients with virological suppression did not have different rates of aging-relating cognitive decline compared with HIV-negative patients.
In older at-risk individuals, even APOE ε4 carriers, a multidomain lifestyle intervention seems to be beneficial.
Cognitive training helps to improve memory in older adults with mild cognitive impairment.
Cognitive therapies may help reduce falls in order adults.
Guidelines: AAN Recommends Exercise, Cautious Prescribing for Patients With Mild Cognitive ImpairmentJanuary 15, 2018
A lower education level was associated with higher MCI prevalence in 8 of the class I studies.
Intake of nutrients in green leafy vegetables is linked to a slower cognitive decline.
Anodal tDCS might not enhance short-term memory in healthy individuals when applied to the left DLPFC.
Charts may help identify individuals who may benefit most from early interventions to help preserve cognition.
HIV-positive individuals with higher alcohol levels performed worse on several cognitive tests, however alcohol was not the primary factor.
In Parkinson's patients who are cognitively normal or have mild cognitive impairment, patterns of cortical β-amyloid and tau are not different.
A population-based cohort study evaluated whether proton pump inhibitor use was associated with an increased risk for dementia.
The ACB scale shows good dose-response relationships between anticholinergic burden and adverse outcomes for older adults.
This analysis was comprised of well-educated and mostly white patients, so these findings may be difficult to generalize to all populations.
HIV patients had reduced brain volume and poorer cognitive performance.
An approximately 1-SD increase in SBP correlated with lower scores for 2 tests that assessed for brain damage, dementia, and task switching.
Patients with HIV treated with cART have lower neuropsychological test scores than controls, but no significant neuropsychological decline over time.
Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.
Evaluating the risk factors of neurocognitive decline in HIV.
Findings from animal studies indicate that anesthetics may be neurotoxic and could result in long-term central nervous system alterations and cognitive dysfunction.
Physicians should provide counseling to adolescents on the effects of marijuana.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
Individuals with prevalent dementia and any nursing home use had especially high 1-year mortality.
Cognitive dysfunction may be the result of lower intracerebral vasomotor reactivity which is linked to PHPT.
Previous reports have suggested that statins or the low levels of LDL cholesterol they promote may have an adverse impact on cognition.
Findings from this trial challenge current recommended systolic blood pressure targets for older adults.
Visual dysfunction is associated with poor cognitive function in older adults.
Cognitive deficits can be caused by sleep-disordered breathing.
Effective cognitive screening instruments are needed in order to assess and manage milder forms of HIV-associated neurocognitive disorders.
Neurology Advisor Articles
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Comparing Reference Points for Deep Brain Stimulation Location in Parkinson Disease
- FDA Approves Clinical Decision Support Tool for Stroke
- US Will Produce Radioisotope for MRI, FDA Says
- Cognitive Decline in Men Linked to Low Serum Sodium
- Solanezumab Every 4 Weeks Does Not Significantly Affect Cognitive Decline in Alzheimer Disease